Viromed Medical AG VME
XETR · Germany · Health Services
€5.90+0.75 (+14.56%)
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
RELLINGEN, GERMANY - September 28, 2026 (NEWMEDIAWIRE) - Viromed Medical AG ("Viromed"; ISIN: DE000A40ZVN7), a medical technology company and pioneer of cold plasma technology, today published its half-year report for 2026. In the first half of 2...
RELLINGEN, GERMANY - September 2, 2026 (NEWMEDIAWIRE) - Viromed Medical AG ("Viromed"; ISIN: DE000A40ZVN7), a medical technology company and pioneer in cold plasma technology, has appointed Prof. Dr. Michael A. Rubhausen to its Medical Advisory B...
RELLINGEN, GERMANY - August 10, 2026 (NEWMEDIAWIRE) - Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company and pioneer in cold plasma technology, has entered into several new distribution partnerships for its ViroCAP(R...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.